Director/PDMR Shareholding

RNS Number : 5853G

MyCelx Technologies Corporation

30 May 2017

 

MYCELX Technologies Corporation   

("MYCELX" or the "Company") (AIM: MYX)

30 May 2017

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). This inside information is now considered to be in the public domain.

Grant of Share Option to Chief Financial Officer

On 26 May 2017 Ms. Slayton was awarded the following options over the Company's common shares of US$0.025 each ("Common Shares") under the MYCELX Omnibus Performance Incentive Plan ("Plan"):

Name	Number of share options granted	Exercise price	Total number of share options held following this notification	Total number of share options as % of current issued share capital
Kimberly Slayton	30,000	US$0.75*	130,000	0.69%

Ms. Slayton holds no Common Shares in the issued capital of the Company.

Grant of Share Option to Chief Business Development Officer

The Company further announces that Mark Mixon, Chief Business Development Officer, was granted an option on 26 May 2017 under the Plan over 35,000 Common Shares. The grant to Mr. Mixon was as follows:

Name	Number of share options granted	Exercise price	Total number of share options held following this notification	Total number of share options as % of current issued share capital
Mark Mixon	35,000	US$0.75*	300,204	1.60%

In addition, following this transaction, Mr. Mixon continues to be interested in 10,000 Common Shares, representing 0.05 per cent of the present issued capital of the Company, which he holds as a custodian.

Grant of Share Option to Chief Executive Officer

The Company further announces that Connie Mixon, Chief Executive Officer, was granted an option on 26 May 2017 under the Plan over 40,000 Common Shares. The grant to Ms. Mixon was as follows:

Name	Number of share options granted	Exercise price	Total number of share options held following this notification	Total number of share options as % of current issued share capital
Connie Mixon	40,000	US$0.75*	203,017	1.08%

Following this award, Connie Mixon, Chief Executive Officer and spouse of Mr. Mixon is interested in an aggregate (including the interests of Mr. Mixon) of 991,211 Common Shares, representing 5.28 per cent of the present issued capital of the Company, and in options over an aggregate (including the interests of Mr. Mixon) of 503,221 Common Shares, representing 2.68 per cent of the present issued capital of the Company.

The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 shares held by or on behalf of Ms. Mixon's children.

The above grants formed part of wider grants of 205,000 options to employees across the Company, on the same date, representing 1.09% of the current issued share capital. 

The share options granted on 26 May 2017 will vest as to 50% on 31 December 2017 and 50% on 31 December 2018, and must be exercised prior to the tenth anniversary of the date of grant, subject to the restrictions on dealing under the Company's share dealing code.

Following the above grants, a total of 1,192,042 share options have been granted to directors and employees and are currently outstanding, representing 6.35% of the issued share capital of 18,770,117 Common Shares. *Based on the closing mid-market price of the Company's Common Shares at 26 May 2017, and the closing US/£ exchange rate at that date.

For further information please contact:

MYCELX Technologies Corporation Connie Mixon, CEO Kim Slayton, CFO	Tel: [phone]
Cantor Fitzgerald Europe - NOMAD and Broker Andrew Craig Richard Salmond	Tel: [phone]
Celicourt Communications Mark Antelme Joanna Boon	Tel: [phone]

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation (No. 596/2014).

Notification of transactions of persons discharging managerial responsibility or connected persons

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Connie Mixon
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mycelx Technologies Corporation
b)	LEI	213800UJZINIK2VD1G48
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Common shares of US$0.025 USU624551078
b)	Nature of the transaction	Grant of share option to Connie Mixon under the Mycelx Omnibus Performance Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) US$0.75 40,000
d)	Aggregated information - Aggregated volume - Price	n/a n/a
e)	Date of the transaction	2017/05/26
f)	Place of the transaction	Grant of the options occurred outside a trading venue.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Connie Mixon
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Mycelx Technologies Corporation
b)	LEI	213800UJZINIK2VD1G48
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Common shares of US$0.025 USU624551078
b)	Nature of the transaction	Grant of share option to spouse, Mark Mixon, under the Mycelx Omnibus Performance Incentive Plan
c)	Price(s) and volume(s)	Price(s) Volume(s) US$0.75 35,000
d)	Aggregated information - Aggregated volume - Price	n/a n/a
e)	Date of the transaction	2017/05/26
f)	Place of the transaction	Grant of the options occurred outside a trading venue.

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com

 

END

 

 

DSHLLFLFETIIVID